
Daiichi Sankyo operates a globally integrated network to ensure that high quality, safe pharmaceutical products are supplied quickly for maximum value. Our supply chain of strategically positioned manufacturing plants in Japan, China, Germany, France, Taiwan, and Brazil-made larger through the addition of Ranbaxy Laboratories-offers seamless procurement, manufacturing and logistics. Our flexible and efficient supply chain structure ensures stable access to raw materials, systematic manufacturing and timely, reliable delivery.

The strength of our more than 5,000-person sales force provides timely and accurate information to clinicians on emerging medical issues and treatment trends. Possessing drive and expertise, these sales representatives will support new entries, such as Azor®/Sevikar®; combination antihypertensive of Olmesartan medoxomil, our flagship product, with Amlodipine, and the anti-platelet Prasugrel(Effient™/Efient®), while sustaining maximum sales for our established products.
